Literature DB >> 30564676

Patients' perspectives on BETTER 2 prevention and screening: qualitative findings from Newfoundland & Labrador.

Nicolette Sopcak1, Carolina Aguilar2, Candace I J Nykiforuk3, Mary Ann O'Brien4, Kris Aubrey-Bassler5, Richard M Cullen6, Melanie Heatherington7, Eva Grunfeld8,9, Donna P Manca10.   

Abstract

BACKGROUND: Chronic disease prevention and screening (CDPS) has been identified as a top priority in primary care. However, primary care providers often lack time, evidence-based tools, and consistent guidelines to effectively address CDPS. Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Primary Care (BETTER) is a novel approach that introduces a new role, that of the prevention practitioner; the prevention practitioner meets with patients, one on one, to undertake a personalised CDPS visit. Understanding patients' perspectives is important for clinicians and other stakeholders aiming to address and integrate CDPS. AIM: To describe patients' perspectives regarding visits with a prevention practitioner in BETTER 2, an implementation study that was carried out after the BETTER trial and featured a higher proportion of patients in rural and remote locations. DESIGN &
SETTING: Qualitative description based on patient feedback surveys, completed by patients in three primary care clinics (urban, rural, and remote) in Newfoundland and Labrador, Canada.
METHOD: Patients' perspectives were assessed based on responses from 91 feedback forms. In total, 154 patients (aged 40-65 years) received ≥1 prevention visit(s) from a prevention practitioner and were asked to provide written feedback. In addition to demographics, patients were asked what they liked about their visit(s), what they would have liked to be different, and invited to make any other comments. Qualitative description was used to analyse the data.
RESULTS: Four main themes emerged from patients' feedback: value of visit (patients appreciated the visit with a prevention practitioner); visit characteristics (the visit was personalised, comprehensive, and sufficiently long); prevention practitioners' characteristics (professionalism and interpersonal skills); and patients' concerns (termination of the programme and access to preventative care).
CONCLUSION: Patients appreciated the visits they received with a prevention practitioner and expressed their desire to receive sustained CDPS in primary care.

Entities:  

Keywords:  chronic disease; patients; primary care; primary prevention

Year:  2017        PMID: 30564676      PMCID: PMC6169935          DOI: 10.3399/bjgpopen17X101037

Source DB:  PubMed          Journal:  BJGP Open        ISSN: 2398-3795


  12 in total

1.  Shared decision making: really putting patients at the centre of healthcare.

Authors:  A M Stiggelbout; T Van der Weijden; M P T De Wit; D Frosch; F Légaré; V M Montori; L Trevena; G Elwyn
Journal:  BMJ       Date:  2012-01-27

2.  Population patterns of chronic health conditions, co-morbidity and healthcare use in Canada: implications for policy and practice.

Authors:  Anne-Marie Broemeling; Diane E Watson; Farrah Prebtani
Journal:  Healthc Q       Date:  2008

Review 3.  Communicating shared decision-making: cancer patient perspectives.

Authors:  Sally Thorne; John L Oliffe; Kelli I Stajduhar
Journal:  Patient Educ Couns       Date:  2012-03-30

4.  Shared decision making: Concepts, evidence, and practice.

Authors:  A M Stiggelbout; A H Pieterse; J C J M De Haes
Journal:  Patient Educ Couns       Date:  2015-07-15

Review 5.  Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status.

Authors:  E A G Joosten; L DeFuentes-Merillas; G H de Weert; T Sensky; C P F van der Staak; C A J de Jong
Journal:  Psychother Psychosom       Date:  2008-04-16       Impact factor: 17.659

Review 6.  What patients want.

Authors:  Jozien Bensing; Michela Rimondini; Adriaan Visser
Journal:  Patient Educ Couns       Date:  2013-03

7.  Guideline harmonization and implementation plan for the BETTER trial: Building on Existing Tools to Improve Chronic Disease Prevention and Screening in Family Practice.

Authors:  Denise Campbell-Scherer; Jess Rogers; Donna Manca; Kelly Lang-Robertson; Stephanie Bell; Ginetta Salvalaggio; Michelle Greiver; Christina Korownyk; Doug Klein; June C Carroll; Mel Kahan; Jamie Meuser; Sandy Buchman; Rebekah M Barrett; Eva Grunfeld
Journal:  CMAJ Open       Date:  2014-01-22

8.  Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial.

Authors:  Eva Grunfeld; Donna Manca; Rahim Moineddin; Kevin E Thorpe; Jeffrey S Hoch; Denise Campbell-Scherer; Christopher Meaney; Jess Rogers; Jaclyn Beca; Paul Krueger; Muhammad Mamdani
Journal:  BMC Fam Pract       Date:  2013-11-20       Impact factor: 2.497

9.  Implementing and evaluating a program to facilitate chronic disease prevention and screening in primary care: a mixed methods program evaluation.

Authors:  Donna Patricia Manca; Kris Aubrey-Bassler; Kami Kandola; Carolina Aguilar; Denise Campbell-Scherer; Nicolette Sopcak; Mary Ann O'Brien; Christopher Meaney; Vee Faria; Julia Baxter; Rahim Moineddin; Ginetta Salvalaggio; Lee Green; Andrew Cave; Eva Grunfeld
Journal:  Implement Sci       Date:  2014-10-08       Impact factor: 7.327

10.  Finding a BETTER way: a qualitative study exploring the prevention practitioner intervention to improve chronic disease prevention and screening in family practice.

Authors:  Donna Patricia Manca; Michelle Greiver; June C Carroll; Ginetta Salvalaggio; Andrew Cave; Jess Rogers; James Pencharz; Carolina Aguilar; Rebekah Barrett; Shelley Bible; Eva Grunfeld
Journal:  BMC Fam Pract       Date:  2014-04-11       Impact factor: 2.497

View more
  1 in total

1.  What is a prevention visit? A qualitative study of a structured approach to prevention and screening - the BETTER WISE project.

Authors:  N Sopcak; C Fernandes; M A O'Brien; D Ofosu; M Wong; T Wong; M Kebbe; D Manca
Journal:  BMC Fam Pract       Date:  2021-07-19       Impact factor: 2.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.